Investor Relations

CHF Solutions is an early stage company focused on commercializing the Aquadex FlexFlow® system. Our objective is to improve the quality of life for patients with heart failure and related conditions, such as fluid overload. CHF Solutions is listed on the NASDAQ Capital Market.

Press Releases

CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Posted on Jun 6, 2017
EDEN PRAIRIE, Minn., June 06, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS), today announced that on May 25, 2017, the independent directors approved two equity awards under CHF Solution's New-Hire Equity Incentive Plan, as material inducements to two individuals entering into employm...

Read More

CHF Solutions' Aquadex Flexflow® Ultrafiltration System Featured in the May 2017 Journal of The American College of Cardiology Review of Ultrafiltration as a Promising Treatment for Fluid Overload Associated with Heart Failure
Posted on Jun 5, 2017
EDEN PRAIRIE, Minn., June 05, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc., (fka Sunshine Heart, Inc.) (NASDAQ:CHFS) announced today that clinical trials using its Aquadex FlexFlow® Ultrafiltration System are featured in the May 2017 Journal of the American College of Cardiology (JACC) Treatm...

Read More

CHF Solutions Retains CORE IR as its Investor Relations Firm of Record
Posted on May 24, 2017
EDEN PRAIRIE, Minn., May 24 2017 (GLOBE NEWSWIRE) – CHF Solutions, Inc. (NASDAQ: CHFS) announced today that it has retained CORE IR as its Investor Relations firm of record. Core IR will provide investor relations and shareholder communications services and assist the company in expanding marke...

Read More

View all press releases »

Events & Presentations

Sunshine Heart First Quarter 2017 Earnings
Posted on May 9, 2017 at 9:00 AM ET
Sunshine Heart Fourth Quarter 2016 Earnings
Posted on Mar 2, 2017 at 9:00 AM ET
Sunshine Heart Third Quarter 2016 Earnings
Posted on Nov 8, 2016 at 9:00 AM ET
View all events & presentations »